Alpha Cognition Inc. Diluted Shares Outstanding (Weighted Average)
Alpha Cognition Inc. (ACOG) reported Diluted Shares Outstanding (Weighted Average) of 21.77 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- Alpha Cognition Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 21.77M shares, a 35.91% increase year-over-year.
- Alpha Cognition Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 21.93M shares, a 36.87% increase year-over-year.
- Alpha Cognition Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 22.57M shares, a 101.42% increase year-over-year.
- Alpha Cognition Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 16.14M shares, a 167.72% increase year-over-year.
- Alpha Cognition Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 17.68M shares, a 143.95% increase from fiscal 2024.
- Alpha Cognition Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 7.25M shares, a 102.15% increase from fiscal 2023.
- Alpha Cognition Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 3.59M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 21.77M shares 10-Q · filed 2026-08-13 | 21.88M shares 10-Q · filed 2026-08-13 | 22.09M shares derived: average of 3 quarters · filed 2026-08-13 | 20.60M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | 21.93M shares 10-Q · filed 2026-05-14 | 22.25M shares derived: average of 2 quarters · filed 2026-05-14 | 20.21M shares derived: average of 3 quarters · filed 2026-05-14 | 19.17M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | 22.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 19.36M shares derived: average of 2 quarters · filed 2026-03-31 | 18.25M shares derived: average of 3 quarters · filed 2026-08-13 | 17.68M shares 10-K · filed 2026-03-31 | ||
| 2025-09-30 | 16.14M shares 10-Q · filed 2025-11-13 | 16.08M shares derived: average of 2 quarters · filed 2026-08-13 | 16.05M shares 10-Q · filed 2025-11-13 | 14.85M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | 16.02M shares 10-Q · filed 2026-08-13 | 16.02M shares 10-Q · filed 2026-08-13 | 14.42M shares derived: average of 3 quarters · filed 2026-08-13 | 12.32M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | 16.02M shares 10-Q · filed 2026-05-14 | 13.61M shares derived: average of 2 quarters · filed 2026-05-14 | 11.09M shares derived: average of 3 quarters · filed 2026-05-14 | 9.82M shares derived: average of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | 11.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 8.62M shares derived: average of 2 quarters · filed 2026-03-31 | 7.75M shares derived: average of 3 quarters · filed 2026-03-31 | 7.25M shares 10-K · filed 2026-03-31 | ||
| 2024-09-30 | 6.03M shares 10-Q · filed 2025-11-13 | 6.02M shares derived: average of 2 quarters · filed 2025-11-13 | 5.93M shares 10-Q · filed 2025-11-13 | 5.33M shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 6.01M shares 10-Q · filed 2025-08-14 | 150.23M shares 10-Q · filed 2024-08-12 | 5.88M shares 10-Q · filed 2025-08-14 | 146.93M shares 10-Q · filed 2024-08-12 | 5.10M shares derived: average of 3 quarters · filed 2025-08-14 | 4.79M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 5.74M shares 10-Q · filed 2025-05-15 | 4.64M shares derived: average of 2 quarters · filed 2025-05-15 | 4.39M shares derived: average of 3 quarters · filed 2025-05-15 | 26.94M shares derived: average of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | 3.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 3.71M shares derived: average of 2 quarters · filed 2025-03-31 | 34.01M shares derived: average of 3 quarters · filed 2025-03-31 | 3.59M shares 10-K · filed 2025-03-31 | ||
| 2023-09-30 | 3.88M shares 10-Q · filed 2024-11-14 | 49.24M shares derived: average of 2 quarters · filed 2024-11-14 | 3.60M shares 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | 94.60M shares 10-Q · filed 2024-08-12 | 86.27M shares 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |